These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis. Latini RA; Buccheri D; Cortese B Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683 [TBL] [Abstract][Full Text] [Related]
10. Neointimal Healing Evaluated by Optical Coherence Tomography after Drug-Eluting Absorbable Metal Scaffold Implantation in de novo Native Coronary Lesions: Rationale and Design of the Magmaris-OCT Study. Karjalainen P; Paana T; Sia J; Nammas W Cardiology; 2017; 137(4):225-230. PubMed ID: 28467998 [TBL] [Abstract][Full Text] [Related]
11. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis. Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147 [TBL] [Abstract][Full Text] [Related]
12. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel. Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654 [No Abstract] [Full Text] [Related]
14. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent. Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059 [No Abstract] [Full Text] [Related]
15. Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery. Gargiulo G; Longo G; Capodanno D; Francaviglia B; Capranzano P; Tamburino C JACC Cardiovasc Interv; 2015 May; 8(6):e95-e97. PubMed ID: 25999117 [No Abstract] [Full Text] [Related]
16. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis? Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841 [TBL] [Abstract][Full Text] [Related]
17. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study. Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242 [TBL] [Abstract][Full Text] [Related]
18. [Coronary stents: what is new?]. Zeus T; Münzel T Dtsch Med Wochenschr; 2014 Apr; 139(14):701-3. PubMed ID: 24668429 [No Abstract] [Full Text] [Related]
19. Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography. Miyazaki T; Ruparelia N; Kawamoto H; Sato K; Latib A; Colombo A Int J Cardiol; 2015; 186():136-8. PubMed ID: 25818756 [No Abstract] [Full Text] [Related]
20. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights. Rivero F; Bastante T; Cuesta J; Benedicto A; Restrepo JA; Alfonso F Can J Cardiol; 2015 Mar; 31(3):255-9. PubMed ID: 25660152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]